Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 543919 | NSE Symbol : MKPL | ISIN : INE964W01021 | Industry : Solvent Extraction |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
06-Feb-2025	13-Feb-2025	Quarterly Results	M. K. Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 inter alia to consider and approve the following items: 1. The Un-Audited Financial Results of the Company for the quarter and nine months ended 31st December 2024; 2. Any other business with the permission of chair. Pursuant to the Regulations 30 and 33 of SEBI (LODR) Regulations, 2015, we hereby inform that the Board of Directors of the Company at its meeting held today i.e. on Thursday, February 13, 2025, inter alia, considered and approved the Un-Audited Financial Results for the quarter and nine months ended December 31, 2024 along with the Limited Review Report thereon by the Statutory Auditors of the Company. A copy of the Un-Audited Financial Results along with Limited Review Report of the Auditors is attached herewith as Annexures. The meeting of the Board of Directors commenced at 05:00 P.M. and concluded at 05:40 P.M. (As Per BSE Announcement Dated on 13.02.2025)
05-Nov-2024	14-Nov-2024	Quarterly Results	M. K. Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve the following businesses: 1. The Un-audited Financial Results of the Company for the quarter and half year ended 30th September 2024; 2. Any other items with the permission of the chairman. Further pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 and the Companys Code of Conduct for prevention of Insider Trading (Code) the Trading Window for trading in Equity shares of the Company will be accordingly re-open after 48 hours from the declaration of the aforesaid Financial Results. Pursuant to the Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Board of Directors of the Company at its meeting held today i.e. on Thursday, November 14, 2024, inter alia, considered and approved the Un-Audited Financial Results for the quarter and half year ended September 30, 2024 along with the Limited Review Report thereon by the Statutory Auditors of the Company. A copy of the Un-Audited Financial Results along with Limited Review Report of the Auditors is attached herewith as Annexures. Please note that the meeting of the Board of Directors commenced at 04:00 p.m. and concluded at 4:30 p.m. You are requested to take the same on your record. (As Per BSE Announcement dated on 14.11.2024)
31-Aug-2024	05-Sep-2024	AGM	M. K. Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2024 inter alia to consider and approve the date time and venue for convening the 12th Annual General Meeting (AGM) of the shareholders of the Company; 2. the draft Notice of 12th Annual General Meeting (AGM) and Directors Report along with applicable annexures thereto; 3. the Book Closure date and Cut-off date for the purpose of 12th Annual General Meeting of the Company This is to inform that the Board of Directors of the Company at their Meeting held on 5th September 2024 discussed and approved the following matters: (i) 12th AGM: The Board has decided that the 12th AGM of the members of M K Proteins Limited be held on Monday, 30th September 2024 at 11:30 AM through VC/OAVM. The Notice of AGM and Annual Report of the Company for the year ended 31st March 2024 will be sent separately to the Stock Exchange(s) and to the Members of the Company. (ii) Book Closure: The Register of Members and Share Transfer Books of the Company will remain close from Tuesday, 24th September 2024 to Monday 30th September 2024 (both days inclusive) for the purpose of holding AGM. Please note that the meeting of the Board of Directors commenced at 11:00 a.m. and concluded at 11:30 a.m. Read less.. (As Per BSE Announcement Dated on 05.09.2024)
05-Aug-2024	13-Aug-2024	Quarterly Results	M. K. Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve the following items: 1. The Un-Audited Financial Results of the Company for the quarter ended 30th June 2024; 2. Any other business with the permission of chair. Pursuant to the Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Board of Directors of the Company at its meeting held today i.e. on Tuesday, August 13, 2024, inter alia, considered and approved: (i) the Un-Audited Financial Results for the quarter ended June 30, 2024 along with the Limited Review Report thereon by the Statutory Auditors of the Company. A copy of the Un-Audited Financial Results along with Limited Review Report of the Auditors is attached herewith as Annexures. (ii) The appointment of M/s. J.P. Jagdev & Co., Company Secretaries, as Secretarial Auditor of the Company to conduct the Secretarial Audit for the financial year 2023-24 and to issue the Secretarial Audit Report thereon; The meeting of the Board of Directors commenced at 03:00 p.m. and concluded at 03:30 p.m (As per BSE Announcement Dated on 13/08/2024)
17-May-2024	29-May-2024	Accounts	M. K. Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve 1. The Audited Financial Results of the Company for the quarter and year ended 31st March 2024; 2. Any other items with the permission of the chairman. Pursuant to the Regulations 30 and 33 of SEBI (LODR) Regulations, 2015, we hereby inform that the Board of Directors of the Company at its meeting held today i.e. on Wednesday, May 29, 2024, inter alia, considered and approved: 1. Audited Standalone Financial Results for the quarter and for the FY ended on 31st March, 2024 together with a statement of Cash Flow, Statement of Assets and Liabilities for the same period; 2. Auditors Report on the said Financial Results; 3. Declaration regarding unmodified opinion on Audited Standalone Financial Results under Regulation 33(3)(d) of the SEBI (LODR) Regulations, 2016; 4. The appointment of K K Sinha & Associates, as Cost Auditors of the Company for the period 2024-25. 5. Related Party Transactions for the Half Year ended 31.03.2024. The meeting of the Board of Directors commenced at 03:00 p.m. and concluded at 4:30 p.m. Read less.. (As Per BSE Announcement Dated on 29.05.2024)
18-Mar-2024	18-Mar-2024	Bonus Issue	With reference to the captioned subject and in terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at their meeting held on today i.e. Monday, March 18, 2024, considered and approved the allotment of 25,02,48,000 Equity Shares of Re. 1/- each by way of bonus issue to such members whose names have appeared in the Register of Members as on March 15, 2024, being the Record Date fixed for the said purpose, in the ratio of 2:1 i.e. 2 (Two) new fully paid up Equity Share of Re. 1/- each for every 1 (One) existing fully paid-up Equity Share of Re. 1/- each held by them. Consequent to said above allotment the issued, subscribed, and paid-up equity share capital of the stand increased to Rs. 37,53,72,000/- consisting of 37,53,72,000 equity shares of face value of Re.1 each. Read less..
17-Jan-2024	30-Jan-2024	Quarterly Results	M. K. Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2024 inter alia to consider and approve the following businesses: 1. Un-audited Financial Results: the Un-Audited Financial Results of the Company for the quarter and nine months ended 31st December 2023 and take note of Limited Review Report issued by the Statutory Auditors of the Company thereon; 2. Bonus Issue: issuance of Bonus Shares to all eligible equity shareholders of the company subject to the approval by the members and all other requisite approvals; 3. Increase in Authorized Capital: to increase in the Authorized Share Capital of the Company and consequent alteration of Clause V of the Memorandum of Association of the Company subject to the approval of the members; 4. Members Approval: to seek necessary members approval these board decisions; 5. Other Items: any other items with the permission of the chairman. Board approved:- 1. BONUS ISSUE TO THE EXISTING SHAREHOLDERS OF THE COMPANY The proposal of issuance of Bonus equity shares to the existing shareholders of the Company in the ratio of 2 : 1 i.e. 2 (Two) fully paid-up bonus equity shares of face value of Re. 1/- (Rupee One Only) each for every 1 (One) existing fully paid-up equity shares having a face value of Re. 1/- (Rupee One Only) each held by the eligible shareholders of the Company as on the record date, subject to the approval of shareholders and such other approvals as may be required. Record date to determine the eligible shareholders shall be decided and will be intimated to the stock exchanges in due course. 2. INCREASE IN AUTHORIZED SHARE CAPITAL OF THE COMPANY The increase in Authorised Share Capital of the Company from Rs. 15,00,00,000 (Rupees Fifteen Crores Only) divided into 15,00,00,000 (Fifteen Crores Only) Equity Shares of Re. 1/- each to Rs. 40,00,00,000 (Rupees Forty Crores Only) divided into 40,00,00,000 (Forty Crores Only) Equity Shares of Re. 1/- each and consequent amendment in the Capital Clause (Clause V) of Memorandum of Association of the Company, subject to the approval of shareholders. 3. MEMBERS' APPROVAL THROUGH POSTAL BALLOT To seek members' approval through the process of postal ballot for the above-said today's board decision and approved the draft notice of Postal Ballot, appointment of scrutinizer and other incidental activities. (As Per BSE Bulletin Dated on 30.01.2024) In terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at their meeting held on Tuesday, January 30, 2024, inter-alia, considered and approved the following business items: 1. UN-AUDITED FINANCIAL RESULTS OF THE COMPANY 2. BONUS ISSUE TO THE EXISTING SHAREHOLDERS OF THE COMPANY 3. INCREASE IN AUTHORIZED SHARE CAPITAL OF THE COMPANY 4. MEMBERS' APPROVAL THROUGH POSTAL BALLOT The notice of the same shall be sent separately to the Stock Exchange(s) and to the Members of the Company and will also be available on the Company''s and stock exchange(s) websites, in due course. The Board meeting commenced at 06:00 P.M. and concluded at 06:30 P.M. The Un-audited Financial Results of the Company for the quarter and nine months ended December 31, 2023, duly reviewed by the Audit committee, along with Limited Review Report for same. In terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at their meeting held on Tuesday, January 30, 2024, inter-alia, considered and approved the following business items: 1. UN-AUDITED FINANCIAL RESULTS OF THE COMPANY 2. BONUS ISSUE TO THE EXISTING SHAREHOLDERS OF THE COMPANY 3. INCREASE IN AUTHORIZED SHARE CAPITAL OF THE COMPANY 4. MEMBERS' APPROVAL THROUGH POSTAL BALLOT (As per BSE Announcement Dated on 30/01/2024)
06-Dec-2023	06-Dec-2023	Others	The Board approved the Capital Expansion Plan at the Board Meeting held today
02-Nov-2023	14-Nov-2023	Quarterly Results	M. K. Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve the un-audited Financial Results for the quarter and half year ended 30th September 2023 M. K. Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 ,inter alia, to consider and approve the unaudited Financial Results for the quarther and half year ended on 30th September 2023 and any other business with the permission of the Chairman. M K PROTEINS LIMITED has informed BSE about Board Meeting to be held on 14 Nov 2023 to consider financial statements for the period ended September 2023. Financial results is Re-schedule and to be held on 10 Nov 2023. (As per BSE Announcement Dated on 10/11/2023) Pursuant to the Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Board of Directors of the Company at its meeting held today i.e. on Tuesday, November 14, 2023, inter alia, considered and approved the Un-Audited Financial Results for the quarter and half year ended September 30, 2023 along with the Limited Review Report thereon by the Statutory Auditors of the Company. A copy of the Un-Audited Financial Results along with Limited Review Report of the Auditors is attached herewith as Annexures. Kindly note that the meeting of the Board of Directors commenced at 05:00 p.m. and concluded at 5:55 p.m. A copy of the Unaudited Financial Results for the quarter and half yearly ended on September 30, 2023 along with Limited Review Report of the Auditors is attached. (As Per BSE Announcement dated on 14.11.2023)
05-Sep-2023	23-Sep-2023	Stock Split	M. K. Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/09/2023 inter alia to consider and approve 1. The proposal for sub division/split of Equity Shares of the Company having a Face value of Rs. 10/- each in such a manner as the Board may determine 2. Consequent alteration of Memorandum of Association of the Company and 3. Any other item with the permission of chairman. We wish to inform you that the Board of Directors of the Company at their meeting held on Saturday, September 23, 2023, inter-alia, considered and approved the following business items: 1. the proposal of sub-division/split of company's 1 (one) Equity Shares of the Company having a face value of Rs. 10/- each into 10 (Ten) Equity shares of the company having face value of Re. 1 each, subject to the approval of shareholders and such other approvals as may be required. 2. the alteration of capital clause of Memorandum of Association of the Company consequent to the sub-division of the face value of the equity shares of the Company, subject to the approval of shareholders of the Company. 3. decided to seek members' approval through the process of postal ballot for the above-said today's board decision and approved the notice of Postal Ballot, process being initiated separately and appointment of Scrutinizer for postal ballot. (As per BSE Announcement Dated on 23/09/2023)
01-Sep-2023	05-Sep-2023	AGM	M. K. Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2023 inter alia to consider and approve the following businesses: 1. To fix the date time and venue for convening the 11th Annual General Meeting (AGM) of the shareholders of the Company; 2. To consider and approve the draft of Notice of 11th Annual General Meeting (AGM) and Directors Report along with applicable annexures thereto; 3. To fix and decide the Book Closure date and Cut-off date for the purpose of 11th Annual General Meeting of the Company; 4. Any other matter with the permission of chair You are requested to kindly take the same on your records. Outcome of the Board Meeting held on 05/09/2023. (As Per BSE Announcement dated on 05.09.2023)
03-Aug-2023	14-Aug-2023	Quarterly Results	M. K. Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve The meeting of the Board of Directors of the Company will be held on Monday 14th August 2023 to inter-alia consider and approve the following items: 1. The Un-Audited Financial Results of the Company for the quarter ended 30th June 2023; 2. Any other business with the permission of chair. the following items: 1. The Un-Audited Financial Results of the Company for the quarter ended 30th June 2023; 2. Any other business with the permission of chair. Further in accordance with Code of Conduct for Prevention of Insider Trading read with SEBI (Prohibition of Insider Trading) Regulations 2015 the Trading Window of the Company was already closed for all the Designated Employees Departmental Heads and Directors of the Company from 1st July 2023 till end of 48 hours after the declaration of Unaudited Financial Results for the quarter ended 30th June 2023. Pursuant to the Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Board of Directors of the Company at its meeting held today i.e. on Monday, August 14, 2023, inter alia, considered and approved the Un-Audited Financial Results for the quarter ended June 30, 2023 along with the Limited Review Report thereon by the Statutory Auditors of the Company. A copy of the Un-Audited Financial Results along with Limited Review Report of the Auditors is attached herewith as Annexures. Kindly note that the meeting of the Board of Directors commenced at 06:00 p.m. and concluded at 06:30 p.m. You are requested to take the same on your record. Pursuant to Regulation 30, 33 and other applicable Regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and with reference to the captioned subject, we hereby inform that, the Board of Directors, at their meeting held today i.e. Monday, August 14, 2023, have inter-alia: 1. Considered, approved and taken on record Un-audited Financial Results of the Company for the Quarter ended on June 30, 2023 as per Indian Accounting Standards (Ind AS) along with the Limited Review Report thereon as received from the Statutory Auditor of the Company; 2. All other business as per Agenda Circulated. We hereby inform that the Board of Directors of the Company at its meeting held today .i.e. on Monday, 14th August, 2023, inter alia,, considered and approved the Unaudited Financial Results for the quarter ended June 30, 2023 along with the Limited Review Report thereon by the Statutory Auditor of the Company. A copy of the Un-audited Financial Results along with Limited Review Report of the Auditor is attached herewith as Annexures. You are requested to take the same on your record. (As Per BSE Announcement Dated on 14.08.2023)
11-Jul-2023	11-Jul-2023	EGM	Pursuant to applicable regulations of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 (SEBI LODR), including Regulation 30, this is to inform you that the Board of Directors of the Company held the Board meeting today, i.e. July 11, 2023 and inter-alia have considered and approved convening of an Extra Ordinary General Meeting ('EGM') of the Equity Shareholders of the Company on Friday, August 4, 2023 through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM') and also approved the Notice for calling the said EGM. The Board Meeting commenced at 03:00 p.m. and concluded at 3:30 p.m.
15-May-2023	25-May-2023	Accounts	Intimation of Meeting of the Board of Directors to consider, approve & take on record Audited Financial Results for half yearly and year ended on March 31, 2023 M K Proteins Limited has submitted to the Exchange, the financial results for the period ended March 31, 2023. M K Proteins Limited has informed the Exchange regarding Board meeting held on May 25, 2023. (As Per NSE Announcement Dated on 25/05/2023)
05-May-2023	05-May-2023	Change in Directors	M K Proteins Limited has informed the Exchange regarding Board meeting held today i.e May 05, 2023. for appointment of Additional Non-Executive Independent Directors of the Company. M K Proteins Limited has informed the Exchange regarding Change in Director(s) of the company.

1 2

LOGIN HERE

M K Proteins Ltd

Board Meeting